Summary. Growth hormone injected intravenously in the rat elicited a 6-fold spike change in immunoreactive insulin with little variation in glucose. Subcutaneous administration of growth hormone for 4 days augmented by 56% the insulin-secretory response to glucose of isolated islets from hypophysectomised rats but not the response of control rat islets. When islets were cultured in the presence of growth hormone, the glucose-induced insulin release was increased by 35 % in batch incubations of islets from both normal and hypophysectomised rats and by 70-110% in perifused islets. Thus the capacity for stimulated release of insulin is limited by hypophysectomy, and growth hormone is capable of directly influencing the secretory function of the/3-cell.
Growth hormone is known to regulate carbohydrate metabolism in dogs and other species [1, 2] . In the dog, administration of growth hormone (GH) causes diabetes [3, 4] accompanied by hyperinsulinaemia [5] , followed after prolonged GH treatment by lowered insulin secretion [6] . In the rat, GH, while not diabetogenic, is able to induce signs of enhanced pancreatic activity [7, 8] . In hypophysectomised but not in normal rats, repeated injections of growth hormone restores to a variable extent the insulin-release response of pancreatic islets incubated with glucose [9, 10] . In the present experiments, we have sought further information on plasma insulin after intravenous injection of growth hormone in normal rats, and on the insulin response to glucose of islets treated directly with growth hormone in culture.
Materials and Methods

Reagents
All chemicals used were of analytical grade. Bovine growth hormone (bGH, National Institutes of Health, U. S. A., lots NIH-GH S 11 and NIH-GHB 18) was dissolved fresh before use (5 mg/ml in 0.154 mol/1 NaCl at pH 8). The bGH solution was insulin-free by radioimmunoassay (RIA) and also free of glucose. Rat insulin standard was a gift from Dr, A.J. Moody, Novo Research Laboratories. Guinea pig anti-insulin serum (Wellcome, lot K6440), and a suspension of charcoal (Norit GSX) were used for insulin radioimmunoassay. Collagenase (Type I) and bovine plasma albumin were from Sigma. ATP, NADP, glucose-6-phosphate dehydrogenase (E. C.t.1.1.49) and hexokinase (E. C. 2.7.1.1.) were from Boehringer. For islet culture, tissue culture medium (Gibco, RPMI-1640 with 25 mmol/1 HEPES) containing 11 mmol/l glucose, 0.5 mg/ml streptomycin, t50 units/ ml penicillin and 10% inactivated normal calf serum (WeUcome, C507) was used in sterile petri dishes.
Animals
Male hypophysectomised rats and paired controls of the Wistar strain were purchased from Charles River Laboratories, and used after 4-5 weeks from hypophysectomy. Regular rat diet (PRM, E. Dixon & Sons (Ware) Ltd.) was supplemented with 5 g/100 ml sucrose in water and free access to NaC1 tablets. Other rats were from the laboratory stock, belonged to the same strain and sex, and were fed on a regular rat diet only.
Infection of Growth Hormone
Normal fed rats of 485-520 g body weight were used. Both left femoral vein and artery were cannulated (nylon cannulae, Portex) under sodium pentobarbitone anaesthesia (20 mg/kg body weight SC, Sagatal). After cannulation, rats were kept in restraining cages and tests performed 2 h after recovery. In 3 rats, bGH, 2 mg/kg 0012-186X/80/0019/0391/$01.20 body weight, was injected subcutaneously. Arterial blood samples (0.5 ml) were taken at 0, 15, 30, 60, 180 and 360 rain. After this test, and in the same rats, bGH (2 mg/kg body weight in 0.2 ml 0.154 mol/1 NaC1, pH 8) was injected via femoral vein, and arterial blood samples (0.5 ml) collected at intervals from 0-60 rain. In another 7 rats, cannulated in an identical way, an intravenous bGH test was preceded by a saline injection test (0.2 ml 0.154 mol/1 NaCI pH 8), In each test, arterial blood samples were collected from -5 to 30 rain. Plasma samples obtained by centrifugation, were stored at -20 ~ until analysed, bGH, 10 rng/kg body weight, was also injected subcutaneously for 4 days in 5 normal and 5 hypophysectomised rats, and the insulin response to glucose of isolated islets was compared with that of islets from paired control rats injected identically with the same volume of solvent (0.154 mol/l NaC1 pH 8).
Incubation of Batches of Islets for Insulin Release
Islets were incubated in batches of 5 in 0.6 ml Krebs-bicarbonate medium [13] pH 7.4, containing bovine plasma albumin, i g/l, and glucose in the indicated concentrations, and gassed with O z : CO2, 95 : 5, v : v, prior to incubation. Afterwards, the islets were settled by centrifugation (position 1, MSE Minor bench centrifuge) and an aliquot of the supernatant was removed. This was suitably diluted with the RIA buffer, and kept at -20 ~ until insulin assay.
Islet Content of Insulin
Batches of 4 islets were extracted in 0.25 ml 0.154 mol/1 NaC1, pH 2, by sonication (15 sec at position 2 on a Soniprobe, Dawe Instruments). The sonicate was diluted and assayed for insulin.
Preparation of Islets
Islets from hypophysectomised rats (140-200 g body weight) and their pair-fed controls (390-500 g body weight) and from stock control rats (200-350 g body weight) were prepared by the eollagenase method [11] . To minimize variation in response due to varying food intake, rats were fasted overnight when islets were to be used immediately without prior culture. Islets to be cultured were obtained from fed rats.
Culture of Islets
Islets were cultured at 37 ~ in an atmosphere of humidified air: CO 2 (95 : 5) in the medium previously described [12] . Usually, 25 islets in 5 ml of medium were cultured with change of medium every 48 h. Islets from normal and hypophysectomised rats were cultured in the presence or absence of growth hormone (10 ~tg/ml) for 4 days, after which insulin release in the absence of bGH was studied. In one series of experiments, after measurement of glucose-stimulated insulin release, the islets were transferred to culture medium without growth hormone for 4 days followed by a second study of insulin release.
Islet Diameter
Islet diameter was measured using an eye-piece micrometer in a Griffin stereoscopic dissecting microscope.
Assay
Immunoreactive bGH was measured by a specific radioimmunoassay [14] . Immunoreactive insulin both in plasma and media was estimated by a charcoal radioimmunoassay [15] . The minimum detectable insulin concentration was 5 mU/1 and the coefficient of variation 5%. Growth hormone at concentrations up to 20 Ixg/ml did not interfere with the radioimmunoassay of insulin. Plasma glucose was determined by the hexokinase method [16] . Values are presented as means _+ SEM (shown in Figures as vertical lines). The probability (P) of no real difference between means was calculated by two-tailed Student's t-test [17] ; differences were considered to be significant for P<0.05. For calculation of SEM and t-test, n-values were the number of rats for in vivo experiments and the number of batches of islets pooled from several rats for in vitro studies.
Perifusion of Islets
A specially designed chamber-bath was used. This consisted of a plexiglass central perifusion chamber (0.1 ml) with an outer bath (70 ml) maintaining temperature at 37 ~ by a circulating pump coupled to a thermocontrolled bath. The solution was perifused upward by a peristaltic pump at the flow rate of 2.5 ml/min. The perifusion solutions were kept at 37 ~ prior to circulation through the chamber and were constantly gassed (O2:CO 2, 95:5, v:v). Solutions consisted of Krebs-Ringer bicarbonate, pH 7.4 [13] containing bovine plasma albumin (0.5 g/100 ml) and glucose as indicated. Islets prepared from two hypophysectomised and two paired control rats were cultured for 4 days in the absence or presence of 10 Ixg/ml bGH. Fifty islets from each type were transferred to each chamber filled with medium. After an equilibration of 45 rain with 2 mmol/1 glucose, 5-rain fractions were collected for 25 min. Then, perifusion with 20 mmol/1 glucose was started and l-rain fractions were obtained for 10 min followed by 5-min samples for an additional 100-min period. Insulin was measured immediately for each experiment, after appropriate dilution of an aliquot of the sample with the RIA buffer. Insulin release was expressed as aU/min per islet and also as the area under the release curve (~tU per islet).
Results
Insulin Secretion in Normal Rats In Vivo
The effects of intravenous bovine growth hormone (bGH) injection on the plasma levels of immunoreactive insulin (IRI) and glucose are compared in Figure 1 with the effects of prior infusion of saline into the same rats. Values of IRI at 0 min were 23 + 5 and 25 + 4 mU/1 before saline and bGH injections respectively: levels of glucose were respectively 4.5 + 0.3 and 5.6 + 0.5 retool/1. The control administration of saline produced no significant change in insulin concentrations. A slow rise in glucose concentrations was observed which did not attain statistical significance. Injection of bGH elicited a marked and prompt increase in IRI. The changes in glucose concentration were not significantly different from those seen at the same time-points during the previous saline injection. The plasma levels of bGH attained were investigated in a further group of 3 rats given the same dose of bGH. IRbGH was increased by 17 + 3, 14 + 2 and 10 _+ 3 mg/1 (P<0.05-<0.001) at 2, 5 and 10 rain, respectively. For comparison, in the same rats injected subcutaneously with the same dose of bGH, the plasma levels of IRbGH rose to a maximum of 26-140 ~g/1 in 1 h, returning to basal at 2 h. IRI concentrations showed no significant change (21 + 6 and 26 + 14 mU/1 at 0 and 1 h, respectively).
Basal IRI Levels
Plasma IRI and glucose were also measured in 12 fed hypophysectomised rats and their fed paired con- (9) a Bovine growth hormone, 10 ~g/ml of medium during first culture only. Batch incubations were done in the absence of growth hormone b Rates of IRI release are given as mean _+ SEM for the number of batches of islets shown in parentheses. No significant differences were observed with islets incubated at 2 mmoI/1 glucose Rates of IRI release at 20 mmol/1 glucose were significantly greater (P <0.001) than at 2 mmol/1 glucose for groups A-D, after the first and second culture periods. For rates of IRI release at 20 mmol/1 glucose after the first culture period significant differences (P <0 Rates of insulin release at 2 mmol/1 glucose of bGHtreated islets from normal rats were higher than rates of other 3 groups of islets (P<0.05). Rates of insulin release at 20 mmol/1. glucose of bGH-treated islets from normal rats were higher than those of normal rat islets, not treated with bGH (P<0.05-<0.01, 72-85 min and 130-180 min) and also higher than rates of release of hypophysectomised rat islets, treated or not with bGH (P<0.05-<0.001, 70-180rain). Rates of insulin release at 20 mmol/l glucose of bGH-treated islets from hypophysectomised rats were higher than those of hypophysectomised rat islets not treated with bGH (P<0.05 at 75 rain; P<0.05-<0.001, from 105-180 min)
trois. IRI was 27 + 6 mU/1 for the controls and 5 + 1 mU/1 for the hypophysectomised rats (P<0.001). Glucose levels were 6.2 _+ 0.2 and 4.2 + 0.3 mmol/1, respectively (P<0.001).
Release of Insulin by Islets after In Vivo Treatment with Growth Hormone
In hypophysectomised rats, bGH given SC for 4 days increased the insulin secretory response to 20 mmol/1 glucose of the pancreatic islets by 56% (P<0.001) above the response of the islets from hypophysectomised rats not treated with bGH (Table 1) . The enhancement brought the secretory rate to 86% of bGH-treated paired controls. However, there was no difference in the response to glucose of islets from the normal rats compared with those from normal rats given bGH subcutaneously. Neither hypophysectomy nor bGH treatment affected the basal rate of insulin release from islets incubated with 2 mmol/1 glucose.
Release of Insulin by Cultured Islets
bGH added during culture for 4 days enhanced the response to 20mmol/1 glucose of islets from hypophysectomised and normal rats by 37% and 34% respectively (P<0.001, Tables 2-3 ). When the islets were cultured for a further 4 days in the absence of bGH (Table 3 ) the responses to 20 mmol/l glucose of islets from hypophysectomised rats were not significantly different from those from control rats. However, for both groups of islets, glucosestimulated insulin release rates were approximately 3-fold higher with islets exposed to bGH during the first culture period.
Release of Insulin by Perifused Islets
The release of insulin by perifused islets from normal and hypophysectomised rats cultured with or without bGH is shown in Figure 2 . The, basal secretion at 2 mmot/1 glucose was slightly lower in islets from hypophysectomised rats whether or not bGH was present during culture. The response to 20 mmol/1 glucose was higher in the control islets than in the islets from hypophysectomised rats, both in the initial and second phases. The presence of bGH during the culture period markedly enhanced the secretory response to 20 mmol/1 glucose of perifused islets from both control and hypophysectomised rats. The integrated areas under the release curves from 70-180rain were as follows (~U/islet): control -bGH: 325 _+ 59; control +bGH: 674 + 50; hypophysectomised -bGH: 133 + 8; hypophysectomised +bGH: 224 + 25. The culture with bGH enhanced the release response to glucose alone by 107% (P<0.01) and 68% (p<0.001) in the perifused control and hypophysectomised rat islets respectively.
Islet Diameter and Insulin Content
In islets from normal rats cultured for 4 days the mean islet diameter was 218 + 9 ~tm (n = 31) and the mean insulin content was 2.7 + 0.2 mU/islet (n = 7). These parameters were not significantly different in islets obtained from hypophysectomised rats nor in islets from normal or hypophysectomised rats when bGH was present in the culture medium.
Discussion
The intravenous injection of bGH in the rat produced a marked increase in plasma IRI, in agreement with the effects observed in dogs after subcutaneous [18] or intravenous [19] administration of bGH. This increase in IRI was not mediated by changes in blood glucose concentration, and in view of its rapidity may represent a direct action of GH on insulin secretion since growth hormone intermediary hormones [20] may not be involved at this stage. Moreover, although glucagon has been shown to be released by GH even before insulin [21, 22] and could therefore mediate GH-induced insulin release, the presence of high glucose levels abolishes GH-elicited glucagon release but amplifies the effect of GH on insulin release [21] . In the present study, the plasma concentration of bGH attained by IV injection was greatly above the physiological range. However, physiological concentrations of bGH have been shown to elicit insulin release in the peffused rat pancreas [21] and in the dog in vivo [19] . To avoid the complexities of the in vivo situation, we therefore studied the secretory behaviour of isolated islets of Langerhans.
The insulin secretory response to glucose of freshly-prepared islets was profoundly influenced by the GH status of the donor rats. In batch-type incubations, we found, as others [9, 10] , that glucosestimulated insulin release was impaired in islets from hypophysectomised rats. Repeated injections of bGH restored to 86% of normal the capacity of the islets from hypophysectomised rats to secrete insulin in response to glucose but did not enhance secretion in islets from normal rats. The impaired secretory response to glucose of islets from hypophysectomised rats persisted throughout a culture period of 4 days and was evident in both batch-type and perifusion experiments. Since secretory data were expressed on a per islet basis, it was important to assess the effect of treatment of the rat on islet mass and fl-cell content. It was shown that cultured islets from hypophysectomised rats were of identical size and insulin content to those from normal rats.
The cultured islet preparation permitted demonstration of a direct effect of GH on islet function in the absence of extrapancreatic factors. The addition of bGH to the culture medium markedly enhanced the insulin secretory response to glucose of islets from hypophysectomised rats and also of islets from control rats in both batch-type and perifusion experiments. Basal insulin release in batch-type experiments was not affected by tiypophysectomy or bGH treatment of the rats nor by the addition of bGH to the culture medium. In perifusion experiments, a marginaUy lower rate of basal insulin release was observed in islets from hypophysectomised rats.
After 8 days in culture, the effect of hypophysectomy on the insulin response to glucose was no longer apparent; a diminished response to glucose was seen compared with 4-day cultured islets in both normal and hypophysectomised groups. However, despite the absence of bGH during the second 4-day culture period, there was a dramatic enhancement of insulin response to glucose in islets that had been cultured with bGH during the first culture period.
It is clear therefore that high concentrations of bGH can produce marked and persistent effects on insulin secretion in addition to an acute effect. The time required for the appearance of the lasting effect both in the GH-treated hypophysectomised rat and directly in the cultured islets is relatively long. Changes related to the biosynthesis of insulin and other proteins within the fl-cell may be suggested. The possibility afforded by the present study of obtaining populations of islets with a modified insulin secretory function represents a useful approach to defining the mechanisms involved in the normal secretory response as well as its modifications by GH. Assessment of the physiological relevance of the lat-ter now requires studies with physiological concentrations of GH. Such studies may require the use of rat GH, although high affinity receptors for bGH have been described in rat hepatocytes [23] .
